Literature DB >> 14700733

Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake.

Shannon N Saldaña1, Eric L Barker.   

Abstract

Although studies have suggested that dopamine can be transported by serotonin transporters (SERTs), such activity has not been characterized at the cloned SERTs. Dopamine and serotonin uptake by human SERT expressed in HEK-293 cells was compared at 37 and 40 degrees C. Elevated temperature was found to alter serotonin transport, but had no significant effect on dopamine transport. These effects led to a 10-fold increase in the serotonin:dopamine transport ratio reflecting an increased preference of SERTs for dopamine as opposed to serotonin at the higher temperature. The effects of 3,4-methylenedioxymethamphetamine (MDMA) on SERT-mediated dopamine transport were also evaluated by pre-incubating SERT-expressing cells with MDMA. The presence of intracellular MDMA caused a decrease in [3H]dopamine uptake but had no effect on [3H]serotonin transport suggesting that intracellular MDMA may be capable of inhibiting transporter function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14700733     DOI: 10.1016/j.neulet.2003.10.032

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations.

Authors:  Lisa M McFadden; Madison M Hunt; Paula L Vieira-Brock; Janice Muehle; Shannon M Nielsen; Scott C Allen; Glen R Hanson; Annette E Fleckenstein
Journal:  Drug Alcohol Depend       Date:  2012-05-28       Impact factor: 4.492

2.  Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation.

Authors:  Mads Breum Larsen; Mark S Sonders; Ole Valente Mortensen; Gaynor A Larson; Nancy R Zahniser; Susan G Amara
Journal:  J Neurosci       Date:  2011-04-27       Impact factor: 6.167

3.  Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.

Authors:  Marios Politis; Kit Wu; Clare Loane; David J Brooks; Lorenzo Kiferle; Federico E Turkheimer; Peter Bain; Sophie Molloy; Paola Piccini
Journal:  J Clin Invest       Date:  2014-02-17       Impact factor: 14.808

4.  Hazard Characterization of Synthetic Cathinones Using Viability, Monoamine Reuptake, and Neuronal Activity Assays.

Authors:  Anne Zwartsen; Michiel E Olijhoek; Remco H S Westerink; Laura Hondebrink
Journal:  Front Neurosci       Date:  2020-01-29       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.